Phagelux, J&J in antibacterial deal

Phagelux Inc. (Shanghai, China) partnered with the consumer unit of Johnson & Johnson (NYSE:JNJ) to develop one or more antibacterial skin care products. Phagelux is to conduct development, while J&J will supply funding and provide advice on protocol strategy and design. J&J's Johnson & Johnson Innovation unit facilitated the deal...